Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Physical functioning and mortality in very old patients on dialysis.

Torino C, Raso FM, van Saase JLCM, Panuccio V, Tripepi R, Vilasi A, Postorino M, Tripepi G, Mallamaci F, Zoccali C.

Arch Gerontol Geriatr. 2019 Jul 27;85:103918. doi: 10.1016/j.archger.2019.103918. [Epub ahead of print]

PMID:
31376743
2.

Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in "Real Life".

Russo D, Tripepi R, Malberti F, Di Iorio B, Scognamiglio B, Di Lullo L, Paduano IG, Tripepi GL, Panuccio VA.

J Clin Med. 2019 Jul 20;8(7). pii: E1066. doi: 10.3390/jcm8071066.

3.

Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.

Ruggiero B, Trillini M, Tartaglione L, Rotondi S, Perticucci E, Tripepi R, Aparicio C, Lecchi V, Perna A, Peraro F, Villa D, Ferrari S, Cannata A, Mazzaferro S, Mallamaci F, Zoccali C, Bellasi A, Cozzolino M, Remuzzi G, Ruggenenti P, Kohan DE; ANSWER Study Organization.

Am J Kidney Dis. 2019 Sep;74(3):338-350. doi: 10.1053/j.ajkd.2019.01.029. Epub 2019 Apr 23.

PMID:
31027883
4.

Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease.

Panuccio V, Pizzini P, Parlongo G, Caridi G, Tripepi R, Mafrica A, Cutrupi S, D'Arrigo G, Porto G, Garofalo C, Provenzano M, Tripepi G, Mallamaci F, Plebani M, Zoccali C.

Clin Chem Lab Med. 2019 Jul 26;57(8):1162-1168. doi: 10.1515/cclm-2018-1227.

PMID:
30753154
5.

Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study.

Mallamaci F, Tripepi R, D'Arrigo G, Porto G, Versace MC, Marino C, Sanguedolce MC, Testa A, Tripepi G, Zoccali C.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1558-1564. doi: 10.1093/ndt/gfy355.

PMID:
30476170
6.

The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease.

Torino C, Panuccio V, Tripepi R, Vilasi A, Postorino M, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 15. doi: 10.1093/ndt/gfy334. [Epub ahead of print]

PMID:
30445469
7.

Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.

Sarafidis PA, Mallamaci F, Loutradis C, Ekart R, Torino C, Karpetas A, Raptis V, Bikos A, Papagianni A, Balafa O, Siamopoulos K, Pisani G, Morosetti M, Del Giudice A, Aucella F, Di Lullo L, Tripepi R, Tripepi G, Jager K, Dekker F, London G, Zoccali C.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1872. doi: 10.1093/ndt/gfy263. No abstract available.

PMID:
30113666
8.

Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.

Sarafidis PA, Mallamaci F, Loutradis C, Ekart R, Torino C, Karpetas A, Raptis V, Bikos A, Papagianni A, Balafa O, Siamopoulos K, Pisani G, Morosetti M, Del Giudice A, Aucella F, Di Lullo L, Tripepi R, Tripepi G, Jager K, Dekker F, London G, Zoccali C.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1542-1548. doi: 10.1093/ndt/gfy147. Erratum in: Nephrol Dial Transplant. 2018 Oct 1;33(10):1872.

PMID:
30007295
9.

Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial.

D'arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2019 May 1;34(5):819-824. doi: 10.1093/ndt/gfy085.

PMID:
29668990
10.

Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients.

Torino C, Pizzini P, Cutrupi S, Tripepi R, Vilasi A, Tripepi G, Mallamaci F, Zoccali C.

Oxid Med Cell Longev. 2017;2017:2801324. doi: 10.1155/2017/2801324. Epub 2017 Dec 6.

11.

Vitamin D and methylarginines in chronic kidney disease (CKD).

Torino C, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.

PLoS One. 2017 Oct 4;12(10):e0185449. doi: 10.1371/journal.pone.0185449. eCollection 2017.

12.

Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients.

Mallamaci F, D'Arrigo G, Tripepi R, Leonardis D, Porto G, Testa A, Abd ElHafeez S, Mafrica A, Versace MC, Provenzano PF, Tripepi G, Mancini P, Zoccali C.

J Hypertens. 2018 Jan;36(1):119-125. doi: 10.1097/HJH.0000000000001530.

PMID:
28858982
13.

Pruritus and quality of life in renal transplant patients.

Panuccio V, Tripepi R, Bellantoni M, Saporito L, Quattrone S, Lacava V, Parlongo G, Tripepi G, Mallamaci F, Zoccali C.

Clin Transplant. 2017 Mar;31(3). doi: 10.1111/ctr.12893. Epub 2017 Jan 6.

PMID:
27988982
14.

Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project.

Gargani L, Sicari R, Raciti M, Serasini L, Passera M, Torino C, Letachowicz K, Ekart R, Fliser D, Covic A, Balafa O, Stavroulopoulos A, Massy ZA, Fiaccadori E, Caiazza A, Bachelet T, Slotki I, Shavit L, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Kraemer TD, Hannedouche T, Panichi V, Wiecek A, Pontoriero G, Sarafidis P, Klinger M, Hojs R, Seiler-Mu├čler S, Lizzi F, Onofriescu M, Zarzoulas F, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C.

Nephrol Dial Transplant. 2016 Dec;31(12):1982-1988. Epub 2016 Sep 26.

PMID:
27672089
15.

The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study.

Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, Covic A, Siamopoulos K, Stavroulopoulos A, Massy ZA, Fiaccadori E, Caiazza A, Bachelet T, Slotki I, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Gueler F, Hannedouche T, Panichi V, Wiecek A, Pontoriero G, Sarafidis P, Klinger M, Hojs R, Seiler-Mussler S, Lizzi F, Siriopol D, Balafa O, Shavit L, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2005-2011. Epub 2016 Sep 22.

16.

Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients.

Zoccali C, Torino C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Ghiadoni L, Thadhani R, Tripepi G, Mallamaci F.

Nutr Metab Cardiovasc Dis. 2016 Jul;26(7):581-589. doi: 10.1016/j.numecd.2016.03.008. Epub 2016 Mar 25.

PMID:
27113290
17.

Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients.

Mallamaci F, Tripepi R, Leonardis D, Mafrica A, Versace MC, Provenzano F, Tripepi G, Zoccali C.

Transplantation. 2016 Oct;100(10):2211-8. doi: 10.1097/TP.0000000000001023.

PMID:
26683511
18.

Subclinical pulmonary congestion is prevalent in nephrotic syndrome.

Marino F, Martorano C, Tripepi R, Bellantoni M, Tripepi G, Mallamaci F, Zoccali C.

Kidney Int. 2016 Feb;89(2):421-8.

PMID:
26444027
19.

Moderator's view: Ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients.

Zoccali C, Tripepi R, Torino C, Tripepi G, Mallamaci F.

Nephrol Dial Transplant. 2015 Sep;30(9):1443-8. doi: 10.1093/ndt/gfv241. Epub 2015 May 28.

PMID:
26022727
20.

High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease.

Bolignano D, Lennartz S, Leonardis D, D'Arrigo G, Tripepi R, Emrich IE, Mallamaci F, Fliser D, Heine G, Zoccali C.

Kidney Int. 2015 Jul;88(1):130-6. doi: 10.1038/ki.2015.27. Epub 2015 Feb 18.

21.

A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based study.

Mallamaci F, Testa A, Leonardis D, Tripepi R, Pisano A, Spoto B, Sanguedolce MC, Parlongo RM, Tripepi G, Zoccali C.

Am J Kidney Dis. 2015 Feb;65(2):294-302. doi: 10.1053/j.ajkd.2014.07.021. Epub 2014 Oct 7.

PMID:
25301104
22.

Paricalcitol and endothelial function in chronic kidney disease trial.

Zoccali C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Politi R, Tripepi G, Ghiadoni L, Thadhani R, Mallamaci F.

Hypertension. 2014 Nov;64(5):1005-11. doi: 10.1161/HYPERTENSIONAHA.114.03748. Epub 2014 Aug 4. Erratum in: Hypertension. 2015 Jun;65(6):e48. Hypertension. 2017 Jul;70(1):e1.

PMID:
25259743
23.

Snoring amplifies the risk of heart failure and mortality in dialysis patients.

Torino C, Mattace-Raso F, van Saase JL, D'Arrigo G, Tripepi R, Tripepi GL, Postorino M, Mallamaci F, Zoccali C; PROGREDIRE Working Group.

Am J Nephrol. 2014;39(6):536-42. doi: 10.1159/000363419. Epub 2014 Jun 12.

PMID:
24943037
24.

A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study.

Mallamaci F, Testa A, Leonardis D, Tripepi R, Pisano A, Spoto B, Sanguedolce MC, Parlongo RM, Tripepi G, Zoccali C.

J Hypertens. 2014 Aug;32(8):1621-8; discussion 1628. doi: 10.1097/HJH.0000000000000224. Erratum in: J Hypertens. 2014 Dec;32(12):2504.

PMID:
24805955
25.

Lung congestion as a risk factor in end-stage renal disease.

Zoccali C, Tripepi R, Torino C, Bellantoni M, Tripepi G, Mallamaci F.

Blood Purif. 2013;36(3-4):184-91. doi: 10.1159/000356085. Epub 2013 Dec 20. Review.

26.

Asymptomatic pulmonary congestion and physical functioning in hemodialysis patients.

Enia G, Torino C, Panuccio V, Tripepi R, Postorino M, Aliotta R, Bellantoni M, Tripepi G, Mallamaci F, Zoccali C; Lung Comets Cohort Working Group.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1343-8. doi: 10.2215/CJN.11111012. Epub 2013 Apr 11.

27.

Pulmonary congestion predicts cardiac events and mortality in ESRD.

Zoccali C, Torino C, Tripepi R, Tripepi G, D'Arrigo G, Postorino M, Gargani L, Sicari R, Picano E, Mallamaci F; Lung US in CKD Working Group.

J Am Soc Nephrol. 2013 Mar;24(4):639-46. doi: 10.1681/ASN.2012100990. Epub 2013 Feb 28.

28.

Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study.

Panuccio V, Enia G, Tripepi R, Aliotta R, Mallamaci F, Tripepi G, Zoccali C.

BMC Nephrol. 2012 Oct 9;13:134. doi: 10.1186/1471-2369-13-134.

29.

Pulmonary congestion and physical functioning in peritoneal dialysis patients.

Enia G, Tripepi R, Panuccio V, Torino C, Garozzo M, Battaglia GG, Zoccali C.

Perit Dial Int. 2012 Sep-Oct;32(5):531-6. Epub 2012 Sep 1.

30.

Chest ultrasound and hidden lung congestion in peritoneal dialysis patients.

Panuccio V, Enia G, Tripepi R, Torino C, Garozzo M, Battaglia GG, Marcantoni C, Infantone L, Giordano G, De Giorgi ML, Lupia M, Bruzzese V, Zoccali C.

Nephrol Dial Transplant. 2012 Sep;27(9):3601-5. doi: 10.1093/ndt/gfs116. Epub 2012 May 9.

PMID:
22573237
31.

Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition.

Zoccali C, Ruggenenti P, Perna A, Leonardis D, Tripepi R, Tripepi G, Mallamaci F, Remuzzi G; REIN Study Group.

J Am Soc Nephrol. 2011 Oct;22(10):1923-30. doi: 10.1681/ASN.2011020175. Epub 2011 Aug 18.

32.

Ultrafiltration intensification in hemodialysis patients improves hypertension but increases AV fistula complications and cardiovascular events.

Curatola G, Bolignano D, Rastelli S, Caridi G, Tripepi R, Tripepi G, Politi R, Catalano F, Delfino D, Ciccarelli M, Mallamaci F, Zoccali C.

J Nephrol. 2011 Jul-Aug;24(4):465-73. doi: 10.5301/JN.2011.7735.

PMID:
21534239
33.

ACE inhibition is renoprotective among obese patients with proteinuria.

Mallamaci F, Ruggenenti P, Perna A, Leonardis D, Tripepi R, Tripepi G, Remuzzi G, Zoccali C; REIN Study Group.

J Am Soc Nephrol. 2011 Jun;22(6):1122-8. doi: 10.1681/ASN.2010090969. Epub 2011 Apr 28.

34.

Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).

Leonardis D, Basta G, Mallamaci F, Cutrupi S, Pizzini P, Tripepi R, Tripepi G, De Caterina R, Zoccali C.

Nutr Metab Cardiovasc Dis. 2012 Sep;22(9):748-55. doi: 10.1016/j.numecd.2010.11.008. Epub 2011 Apr 5.

PMID:
21470837
35.

[Confounding in epidemiology].

Provenzano F, Versace MC, Tripepi R, Zoccali C, Tripepi G.

G Ital Nefrol. 2010 Nov-Dec;27(6):664-7. Italian. No abstract available.

PMID:
21132649
36.

Use of grafting to prevent Hypsipyla grandella (Zeller) (Lepidoptera: Pyralidae) damage to new world Meliaceae species.

Perez J, Eigenbrode SD, Hilje L, Tripepi RR, Aguilar ME, Mesen F.

Neotrop Entomol. 2010 Jul-Aug;39(4):618-25.

PMID:
20878001
37.

Detection of pulmonary congestion by chest ultrasound in dialysis patients.

Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C.

JACC Cardiovasc Imaging. 2010 Jun;3(6):586-94. doi: 10.1016/j.jcmg.2010.02.005.

38.

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease.

Basta G, Leonardis D, Mallamaci F, Cutrupi S, Pizzini P, Gaetano L, Tripepi R, Tripepi G, De Caterina R, Zoccali C.

Kidney Int. 2010 Feb;77(3):225-31. doi: 10.1038/ki.2009.419. Epub 2009 Nov 18.

39.

Sleep disordered breathing in renal transplant patients.

Mallamaci F, Leonardis D, Tripepi R, Parlongo G, Catalano C, Tripepi G, Castronovo V, Ferini-Strambi L, Zoccali C.

Am J Transplant. 2009 Jun;9(6):1373-81. doi: 10.1111/j.1600-6143.2009.02653.x. Epub 2009 May 20.

40.

Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function.

Addabbo F, Mallamaci F, Leonardis D, Tripepi R, Tripepi G, Goligorsky MS, Zoccali C.

Nephrol Dial Transplant. 2007 Dec;22(12):3521-6. Epub 2007 Jul 17.

PMID:
17636056
41.

Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study.

Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C.

J Am Soc Nephrol. 2007 Apr;18(4):1316-22. Epub 2007 Mar 14.

42.

Left atrial volume in end-stage renal disease: a prospective cohort study.

Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C.

J Hypertens. 2006 Jun;24(6):1173-80.

PMID:
16685218
43.

Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients.

Panuccio V, Tripepi R, Tripepi G, Mallamaci F, Benedetto FA, Cataliotti A, Bellanuova I, Giacone G, Malatino LS, Zoccali C.

Am J Kidney Dis. 2004 Mar;43(3):479-84.

PMID:
14981606
44.

Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.

Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, Bellanuova I, Tripepi R, Seminara G, Parlongo S, Stancanelli B, Bonanno G, Fatuzzo P, Rapisarda F, Belluardo P, Signorelli SS, Heublein DM, Lainchbury JG, Leskinen HK, Bailey KR, Redfield MM, Burnett JC Jr.

Mayo Clin Proc. 2001 Nov;76(11):1111-9.

PMID:
11702899
45.

Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.

Zoccali C, Mallamaci F, Asahia K, Benedetto FA, Tripepi G, Tripepi R, Nicocia G, Buemi M, Miyata T.

J Nephrol. 2001 Jul-Aug;14(4):293-8.

PMID:
11506253
46.

Gender-dependent differences in plasma leptin in essential hypertension.

Mallamaci F, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tripepi R, Zoccali C.

Am J Hypertens. 2000 Aug;13(8):914-20.

PMID:
10950400
47.

Supplemental Content

Loading ...
Support Center